# Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01)

> **NCT03230175** · PHASE2 · COMPLETED · sponsor: **BioTissue Holdings, Inc** · enrollment: 32 (actual)

## Conditions studied

- Non-healing Wound
- Non-healing Diabetic Foot Ulcer
- Diabetic Foot Infection

## Interventions

- **BIOLOGICAL:** TTAX01
- **PROCEDURE:** Surgical resection and debridement
- **DRUG:** Systemic antibiotics
- **DEVICE:** Off-loading

## Key facts

- **NCT ID:** NCT03230175
- **Lead sponsor:** BioTissue Holdings, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-04
- **Primary completion:** 2019-01-10
- **Final completion:** 2019-04-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03230175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03230175, "Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03230175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*